Universität zu Köln

Kloth, M. and Buettner, R. (2016). Where does molecular pathology make sense? Onkologe, 22 (1). S. 13 - 18. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Full text not available from this repository.

Abstract

Background. The increasing importance of molecular pathology in routine oncological diagnostics. Objective. Current recommendations, developments and future applications of molecular pathology in the clinical course of malignant melanoma, colorectal cancer and non-small cell lung cancer (NSCLC). Material and methods. The article is based on a literature review investigating clinically relevant aspects of molecular diagnostics in various databases, e.g. PubMed, the European Society of Medical Oncology (ESMO) and the World Health Organization (WHO). Results and conclusion. The translation of preclinical research and the application in clinical practice are characterized by an increasing speed. The advanced classification of malignant diseases is of high relevance in current therapeutic approaches.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Kloth, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Buettner, R. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-291026
DOI:	10.1007/s00761-015-2997-y
Journal or Publication Title:	Onkologe
Volume:	22
Number:	1
Page Range:	S. 13 - 18
Date:	2016
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1433-0415
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language 1ST-LINE TREATMENT; ADVANCED MELANOMA; IMPROVED SURVIVAL; LUNG-CANCER; OPEN-LABEL; MUTATIONS; VEMURAFENIB; BLOCKADE; IMATINIB; PHASE-3 Multiple languages Oncology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/29102